Rosch to develop glucose sensor system
This article was originally published in Clinica
Executive Summary
Rosch AG Medizintechnik is to develop a noninvasive sensor system for monitoring blood glucose levels. The Berlin-based company, which has interests in the dental and ENT sectors and which is responsible for the European marketing of Equidyne's Injex needle-free injection system, is developing the sensor in collaboration with Prof M Knoll of the Institute for Chemical and Biosensors in Munster, Germany and an unnamed industrial partner.